药物对比
Exenatide vs Saxagliptin
比较 Exenatide（Byetta/Bydureon，GLP-1注射剂）与 Saxagliptin（Onglyza，口服DPP-4抑制剂）治疗2型糖尿病：疗效、减重、副作用及心血管风险。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when selecting between an injectable GLP-1 receptor agonist and an oral DPP-4 inhibitor for type 2 diabetes after metformin.
结论
Exenatide generally delivers superior glycemic control and weight reduction versus Saxagliptin, though oral convenience and differing safety profiles make the choice highly individual.
全部药物对比